graphene colloidal antiviral
Investor.Coffee (05.06.2024): Energy Fuels Announces Q1-Results and Uranium Ramp-Up, Appia Announces Confirmation of MREO/HREOs in Brazil, and ARR Demonstrate High REE Recovery Rates
Energy Fuels Inc. (NYSE American: UUUU | TSX: EFR) has made significant strides in expanding its rare earth elements…
Search by Month
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
-
Zentek is well positioned to commercialize several revolutionary nanotech graphene health products in 2022
Zentek Ltd. (TSXV: ZEN) (formerly ZEN Graphene Solutions Ltd.) is a trail blazing company in the world of …
1 CommentInvestorNews
IN8 Member News
-
DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
-
Independent Studies Further Validate the American Rare Earths’ (ARR) Halleck Creek Project
-
Appia Announces Preliminary Desorption Results and Confirms Ionic Adsorption Clay Rare Earth Mineralization in Brazil
-
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
-
Australian Strategic Materials Limited: Entitlement Offer Open
